Discussion Topic: Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Yasser Rodriguez, MBA, MD, Cleveland Clinic Florida to discuss premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease.
Host: William Sauer, MD, FHRS, CCDS
Guests: Edward Gerstenfeld, MD, MS, FHRS & Yasser Rodriguez, MBA, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources

Podcasts
The Lead Episode 123: A Discussion of Re-Ablation of Atrial Fibrillation Targeting Electrogram Dispersion – The RESTART Trial LIVE at HRX
October 16, 2025

Podcasts
The Lead Episode 122: A Discussion of Telemedicine-Based Management of Atrial Fibrillation in Village Clinics a Cluster Randomized Trial, LIVE at HRX
October 9, 2025

Podcasts
The Lead Episode 121: A Discussion of Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia, LIVE at HRX
October 2, 2025